Dialectical behavior therapy for borderline personality disorder: research progress and challenges
Sichuan Mental Health.2025;38(1):1-6. doi:10.11886/scjsws20250113002
Sichuan Mental Health
2002 (v1, n1) to Present ISSN: 1671-8925
Year of publication
Sort by
Format:
Per page:
Dialectical behavior therapy for borderline personality disorder: research progress and challenges
Sichuan Mental Health.2025;38(1):1-6. doi:10.11886/scjsws20250113002
Sichuan Mental Health.2025;38(1):7-13. doi:10.11886/scjsws20240605002
Effect of target characteristics on prospective memory in patients with depressive disorder
Sichuan Mental Health.2025;38(1):14-21. doi:10.11886/scjsws20240303001
Sichuan Mental Health.2025;38(1):22-27. doi:10.11886/scjsws20240614001
Sichuan Mental Health.2025;38(1):28-33. doi:10.11886/scjsws20240506002
Sichuan Mental Health.2025;38(1):34-40. doi:10.11886/scjsws20240722003
Sichuan Mental Health.2025;38(1):41-45. doi:10.11886/scjsws20240428001
Analysis of latent profiles and influencing factors of sleep in first-trimester pregnant women
Sichuan Mental Health.2025;38(1):46-52. doi:10.11886/scjsws20241002002
Sichuan Mental Health.2025;38(1):53-58. doi:10.11886/scjsws20240402002
Sichuan Mental Health.2025;38(1):59-64. doi:10.11886/scjsws20240509004
Country
China
Publisher
Editorial Office of Sichuan Mental Health
ElectronicLinks
http://www.psychjm.net.cn/Editor-in-chief
TANG Xiangdong
scjsws2022@126.com
Abbreviation
SCMH
Vernacular Journal Title
四川精神卫生
ISSN
1007-3256
EISSN
Year Approved
2023
Current Indexing Status
Currently Indexed
Start Year
1988
Description
Sichuan Mental Health was founded in 1988 and is an academic journal in the field of psychiatry (cn-51-1457 / R, issn1007-3256). Officially approved by the former National Science and Technology Commission, the journal is governed by Sichuan Provincial Commission of Health and sponsored by Sichuan Provincial Mental Health Center. Our mission is to lead research and innovation in psychiatric medicine, disseminate the latest achievements in psychiatric research, focus on clinical needs, and strive to improve the level of clinical practice, teaching, research and prevention in the field. The journal is currently being indexed by leading journal databases in China: China Core Journal (Selection) Database, SinoMed, Chinese Academic Journal Comprehensive Evaluation Database, Chinese Journal Full-text Database, China Chief Medical Network etc. If you are an author: The journal has opened up a "green channel" to speed up publication for the following article types: Articles of funded projects Prospective, multicenter, randomized controlled study with large sample Articles of preventive medicine and epidemiological investigation Basic experimental research on pathogenesis, development and prognosis of disease High quality cutting-edge comment, research and outlook The journal is setting up lists of "Excellent Authors" and "Authors of the Future". We look forward to working with excellent authors and plans to collaborate with Sichuan Mental Health Training Base to provide support to authors of great potential. The journal is honored to have a group of leading experts in mental health and related fields to review manuscripts and provide guidance. We welcome clinical nursing staff, researchers and postgraduate students in the field from hospitals, universities and scientific research institutes to submit manuscripts. If you are a reader: The journal values the needs of our readers. We welcome readers to send letters, raise questions and discuss with authors and editors. We look forward to your comments on published articles. We believe that open discussion is one of best ways to encourage the development of open science. If you are an expert: The journal is continuously improving our editorial board and the reviewers’ team. We expect prominent clinical and scientific researchers to join us as our reviewers, young reviewers and editorial board members. We will make joint efforts to promote the development of psychiatry. Please scan the QR code below to follow our WeChat or to join our QQ Group.